Polymorphisms in gene UGT1A1 modify the association of prenatal exposure to polycyclic aromatic hydrocarbons with congenital heart diseases risk

References

• Zhang Y, Tao S. Global atmospheric emission inventory of polycyclic aromatic hydrocarbons (PAHs) for 2004. Atmos Environ. 2009;43:812–819.
   Web of Science ®Google Scholar
• Suzuki K, Yoshinaga J. Inhalation and dietary exposure to polycyclic aromatic hydrocarbons and urinary 1-hydroxypyrene in non-smoking university students. Int Arch Occup Environ Health. 2007;81(1):115–121.
   PubMed Web of Science ®Google Scholar
• Patel J, Nembhard WN, Politis MD, et al. Maternal occupational exposure to polycyclic aromatic hydrocarbons and the risk of isolated congenital heart defects among offspring. Environ Res. 2020;186:109550.
   PubMed Web of Science ®Google Scholar
• Lupo PJ, Langlois PH, Reefhuis J, et al. Maternal occupational exposure to polycyclic aromatic hydrocarbons: effects on gastroschisis among offspring in the national birth defects prevention study. Environ Health Perspect. 2012;120(6):910–915.
   PubMed Web of Science ®Google Scholar
• Choi H, Rauh V, Garfinkel R, et al. Prenatal exposure to airborne polycyclic aromatic hydrocarbons and risk of intrauterine growth restriction. Environ Health Perspect. 2008;116(5):658–665.
   PubMed Web of Science ®Google Scholar
• Farwell A, Nero V, Croft M, et al. Modified Japanese medaka embryo-larval bioassay for rapid determination of developmental abnormalities. Arch Environ Contam Toxicol. 2006;51(4):600–607.
   PubMed Web of Science ®Google Scholar
• Incardona JP, Collier TK, Scholz NL. Defects in cardiac function precede morphological abnormalities in fish embryos exposed to polycyclic aromatic hydrocarbons. Toxicol Appl Pharmacol. 2004;196(2):191–205.
   PubMed Web of Science ®Google Scholar
• Lupo PJ, Symanski E, Langlois PH, et al. Maternal occupational exposure to polycyclic aromatic hydrocarbons and congenital heart defects among offspring in the national birth defects prevention study. Birth Defects Res A Clin Mol Teratol. 2012;94(11):875–881.
   PubMedGoogle Scholar
• Shimada T, Fujii-Kuriyama Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci. 2004;95(1):1–6.
   PubMed Web of Science ®Google Scholar
• Yang H, Shi Z, Wang X-X, et al. Phenanthrene, but not its isomer anthracene, effectively activates both human and mouse nuclear receptor constitutive androstane receptor (CAR) and induces hepatotoxicity in mice. Toxicol Appl Pharmacol. 2019;378:114618.
   PubMed Web of Science ®Google Scholar
• Chen B, Hu Y, Jin T, et al. The influence of metabolic gene polymorphisms on urinary 1-hydroxypyrene concentrations in Chinese coke oven workers. Sci Total Environ. 2007;381(1–3):38–46.
   PubMed Web of Science ®Google Scholar
• Nerurkar PV, Okinaka L, Aoki C, et al. CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiol Biomarkers Prev. 2000;9:1119–1122.
   PubMed Web of Science ®Google Scholar
• Li N, Mu Y, Liu Z, et al. Assessment of interaction between maternal polycyclic aromatic hydrocarbons exposure and genetic polymorphisms on the risk of congenital heart diseases. Sci Rep. 2018;8(1):3075.
   PubMedGoogle Scholar
• Deng K, Liu Z, Lin Y, et al. Periconceptional paternal smoking and the risk of congenital heart defects: a case-control study. Birth Defects Res A Clin Mol Teratol. 2013;97(4):210–216.
   PubMedGoogle Scholar
• Strickland P, Kang D. Urinary 1-hydroxypyrene and other PAH metabolites as biomarkers of exposure to environmental PAH in air particulate matter. Toxicol Lett. 1999;108(2–3):191–199.
   PubMed Web of Science ®Google Scholar
• Li M, Wang Q, Zhu J, et al. A simple analytical method of determining 1-hydroxypyrene glucuronide in human urine by isotope dilution with ultra performance liquid chromatography–tandem mass spectrometry. Anal Bioanal Chem. 2017;409(6):1513–1518.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang S, Li H, et al. Association of UGT1A1 variants and hyperbilirubinemia in breast-fed full-term Chinese infants. PLOS One. 2014;9(8):e104251.
   PubMed Web of Science ®Google Scholar
• Deming SL, Zheng W, Xu W-H, et al. UGT1A1 genetic polymorphisms, endogenous estrogen exposure, soy food intake, and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2008;17(3):563–570.
   PubMed Web of Science ®Google Scholar
• Abbasi A, Deetman PE, Corpeleijn E, et al. Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study. Diabetes. 2015;64(4):1459–1469.
   PubMed Web of Science ®Google Scholar
• Long J, Zhang S, Fang X, et al. Association of neonatal hyperbilirubinemia with uridine diphosphate-glucuronosyltransferase 1A1 gene polymorphisms: meta-analysis. Pediatr Int. 2011;53(4):530–540.
   PubMed Web of Science ®Google Scholar
• Shin HJ, Kim JY, Cheong HS, et al. Functional study of haplotypes in UGT1A1 promoter to find a novel genetic variant leading to reduced gene expression. Ther Drug Monit. 2015;37(3):369–374.
   PubMed Web of Science ®Google Scholar
• Xu H-M, Xu L-F, Hou T-T, et al. GMDR: versatile software for detecting gene–gene and gene–environment interactions underlying complex traits. Curr Genomics. 2016;17(5):396–402.
   PubMed Web of Science ®Google Scholar
• Mensah GA, Brown DW. An overview of cardiovascular disease burden in the United States. Health Aff. 2007;26(1):38–48.
   PubMed Web of Science ®Google Scholar
• Krauss RS, Hong M. Gene–environment interactions and the etiology of birth defects. Curr Top Dev Biol. 2016;116:569–580.
   PubMed Web of Science ®Google Scholar
• Riedmaier S, Klein K, Hofmann U, et al. UDP-glucuronosyltransferase (UGT) polymorphisms affect atorvastatin lactonization in vitro and in vivo. Clin Pharmacol Ther. 2010;87(1):65–73.
   PubMed Web of Science ®Google Scholar
• Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol. 2000;40:581–616.
   PubMed Web of Science ®Google Scholar
• Miners JO, McKinnon RA, Mackenzie PI. Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance. Toxicology. 2002;181–182:453–456.
   PubMed Web of Science ®Google Scholar
• Mehrad-Majd H, Haerian MS, Akhtari J, et al. Effects of Gly71Arg mutation in UGT1A1 gene on neonatal hyperbilirubinemia: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2019;32:1575–1585.
   PubMed Web of Science ®Google Scholar
• Ravikanth VV, Rao GV, Govardhan B, et al. Polymorphisms in UGT1A1 gene predispose South Indians to pigmentous gallstones. J Clin Exp Hepatol. 2016;6(3):216–223.
   PubMedGoogle Scholar
• Yu Q, Zhang T, Xie C, et al. UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy. Cancer Chemother Pharmacol. 2018;82(1):87–98.
   PubMed Web of Science ®Google Scholar
• Buch S, Schafmayer C, Völzke H, et al. Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition. Gastroenterology. 2010;139(6):1942–1951.e2.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yin J-F, Zhang J, et al. UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis. Cancer Chemother Pharmacol. 2017;80(1):135–149.
   PubMed Web of Science ®Google Scholar
• Sato H, Uchida T, Toyota K, et al. Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G > A (G71R) mutation becomes a risk factor under inadequate feeding. J Hum Genet. 2013;58(1):7–10.
   PubMed Web of Science ®Google Scholar